View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
HHS/CMS RIN: 0938-AT59 Publication ID: Spring 2019 
Title: Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs for Contract Year 2020 (CMS-4185-F) 
Abstract:

This final rule sets forth programmatic and operational changes to the Medicare Advantage (MA) and prescription drug benefit programs for contract year 2020. The second final action will address the Medicare Advantage risk adjustment data validation provisions.

 
Agency: Department of Health and Human Services(HHS)  Priority: Economically Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Proposed Rule Stage 
Major: Yes  Unfunded Mandates: No 
EO 13771 Designation: Deregulatory 
CFR Citation: 42 CFR 417    42 CFR 422 and 423   
Legal Authority: 42 U.S.C. 1302    42 U.S.C. 1395hh   
Legal Deadline:
Action Source Description Date
Final  Statutory  MMA sec. 902 requires Medicare final rules publish within 3 years of a proposed or interim final rule.  11/01/2021 

Overall Description of Deadline: Per the CMS notice published December 30, 2004 (69 FR 78442), except for certain Medicare payment regulations and certain other statutorily-mandated regulations, we schedule all Medicare final regulations for publication within the 3-year standardized time limit in the current Unified Agenda. We do not intend to delay publishing a Medicare final regulation for 3 years if we are able to publish it sooner.

Timetable:
Action Date FR Cite
NPRM  11/01/2018  83 FR 54982   
NPRM Comment Period Extended (RADV Only)  12/27/2018  83 FR 66661   
NPRM Comment Period End  12/31/2018 
NPRM Comment Period Extended End (RADV Only)  04/30/2019 
Second NPRM Comment Period Extended (RADV Only)  04/30/2019  84 FR 18215   
Second NPRM Comment Period Extended End  08/28/2019 
Final Action  04/16/2019  84 FR 15680   
Final Action Effective  01/01/2020 
Second Final Action  11/00/2021 
Regulatory Flexibility Analysis Required: No  Government Levels Affected: Federal 
Federalism: No 
Included in the Regulatory Plan: Yes 
RIN Data Printed in the FR: No 
Agency Contact:
Michael Dibella
Director, Division of Policy, Analysis, and Planning
Department of Health and Human Services
Centers for Medicare & Medicaid Services
Center for Medicare, MS: C4-22-18, 7500 Security Boulevard,
Baltimore, MD 21244
Phone:410 786-4480
Email: michael.dibella@cms.hhs.gov